Rick Doblin, founder of MAPS (Multidisciplinary Association for Psychedelic Studies) talks about the opportunity for reflection, healing and unification available during this period of retreat and social distancing due to Coronavirus. MAPS is a non-profit organization that has spent the last 35 years in an effort to get MDMA approved for therapeutic use. They are now in Phase 3 clinical trials for MDMA, the last hurdle before it becomes a prescribable drug. Their studies show that PTSD sufferers show no sign of the disorder one year after receiving MDMA therapy in almost 70% of the cases.